HOME >> MEDICINE >> NEWS
New generation of smallpox vaccines to be tested at Saint Louis University

ST. LOUIS - Two new investigational smallpox vaccines will be studied as part of a clinical trial starting soon at Saint Louis University's Center for Vaccine Development. Saint Louis University is the only location in the United States participating in the trial.

The investigational vaccines, manufactured by Massachusetts-based Acambis Inc., will be compared with the existing smallpox vaccine, known as Dryvax. The new vaccines were produced using modern methods of cell cultivation. Dryvax, the same smallpox vaccine that was provided to all U.S. residents during the period of routine smallpox vaccination, hasn't been produced in many years.

"Although there has not been a case of smallpox in the United States since 1949, the U.S. government has determined that it is necessary to keep smallpox vaccine available, in case the disease is reintroduced through bioterrorism," said Sharon Frey, M.D., principal investigator for the study and associate professor of internal medicine in the division of infectious diseases at Saint Louis University School of Medicine. "A study starting this fall at Saint Louis University is being done to determine the effectiveness of two new investigational smallpox vaccines in healthy adults."

The study will include 90 adult volunteers: 30 receive one newly produced smallpox vaccine, 30 receive the other new vaccine and 30 will receive Dryvax. Like the two newly manufactured vaccines, Dryvax is also considered investigational because researchers will use a different "diluent" to change the vaccine from its dry state (how it's stored) to its liquid state (how it's administered).

"The effectiveness of these smallpox vaccines will be measured by observing whether or not a 'pock,' which resembles a blister, forms at the site of the vaccination, and through blood tests," Frey said. The pock is a typical response to smallpox vaccination and leaves a small scar or depression on the skin at the site of vaccination.
'"/>

Contact: Joe Muehlenkamp
muehlenk@slu.edu
314-977-8015
Saint Louis University
19-Aug-2003


Page: 1 2

Related medicine news :

1. New generation contact lenses cut risk of severe eye infection
2. Genetics important in age-related macular degeneration
3. Gene for age-related macular degeneration discovered by Yale researchers
4. UCSD-Utah team develops mouse model to test therapies for macular degeneration
5. Next generation body scanner launched by the University of Manchester
6. Penn study shows how next-generation diabetic drugs could work more selectively
7. Get ready for next generation surround sound
8. Macular degeneration patients benefit from self-management training
9. New programme will train the next generation of health leaders
10. Pegaptanib provides benefit for neovascular age-related macular degeneration
11. New clue to nerve growth may help regeneration efforts

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New generation smallpox vaccines tested Saint Louis University

(Date:4/21/2015)... One of the most difficult aspects ... food cravings. Many diets end badly due to dieters’ ... Some attempt to eat more often throughout the day, ... regular intervals. While this approach does work for many, ... after a meal. For those who are having trouble ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 The ... of Science in Health Informatics to answer the ... data into a meaningful, comprehensive wellness profile for ... critical to the development and implementation of health ... administrative, clinical, financial and managerial operations in the ...
(Date:4/21/2015)... April 21, 2015 As nationally ... involved in various components of breast reconstruction research ... , "Breast reconstruction research continues to significantly ... Despite recent advances, many unanswered questions remain requiring ... with optimal results," says Dr. Oscar Ochoa emphasizing ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 CALNOC, the ... Burnes Bolton, DrPH, RN, FAAN, will keynote their upcoming ... in Long Beach, CA on October 26, 2015. ... the American Organization of Nurse Executives (AONE) and the ... president of the American Academy of Nursing and the ...
(Date:4/21/2015)... 2015 Dr. Zain Kadri, a Beverly ... infographic that takes a close look at the rise of ... which appears on both Dr. Kadri’s website and RedOrbit ... in the Age of the Selfie.” According to Dr. Kadri, ... to a variety of A-list patients, the trend of taking ...
Breaking Medicine News(10 mins):Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 2Health News:Diet Doc Introduces New Neuro Balance, A Proprietary Diet Aid to Help Dieters Eliminate Food Cravings 3Health News:The University of Scranton Launches Online MS in Health Informatics 2Health News:The University of Scranton Launches Online MS in Health Informatics 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:Nationally Recognized Nurse Leader Linda Burnes Bolton to Present Keynote Address at CALNOC Conference 2Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2
(Date:4/21/2015)... 21, 2015 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: ... of medical devices worldwide, today announced that it will ... Mar 31, 2015 after the U.S. market closes on ... conference call at 8:00 AM on May 12, 2015 ... Beijing/Hong Kong Time). Dial-in details for ...
(Date:4/21/2015)... SAN JOSE, Calif. , April 21, 2015 ... pioneered the use of the iFuse Implant System, ... fusion for certain disorders of the sacroiliac (SI) ... has joined the company,s board of directors effective ... Managing Director for Fidelity Health Insurance Services, LLC.  ...
(Date:4/21/2015)... 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... regenerative medicine, today announced that the abstract describing long-term ... the Phase 2 clinical trial of the Company,s autologous  ... for an oral presentation at the 2015 American Society ... in Chicago, Illinois May 29 ...
Breaking Medicine Technology:Mindray to Report 2015 First Quarter Financial Results on May 11, 2015 2SI-BONE, Inc. Announces Appointment of Fidelity Health Insurance Services, LLC's Martin Watson to Board of Directors 2SI-BONE, Inc. Announces Appointment of Fidelity Health Insurance Services, LLC's Martin Watson to Board of Directors 3Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 2Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 3
Cached News: